Prophylactic tranexamic acid doesn't cut postpartum bleeding

August 23, 2018

(HealthDay)—Prophylactic administration of tranexamic acid does not reduce postpartum hemorrhage among women with vaginal delivery receiving prophylactic oxytocin, according to a study published in the Aug. 23 issue of the New England Journal of Medicine.

Loïc Sentilhes, M.D., Ph.D., from Bordeaux University Hospital in France, and colleagues randomized 4,079 women in labor with a planned vaginal delivery at 35 or more weeks of gestation to tranexamic acid or placebo, administered intravenously, in addition to prophylactic oxytocin after delivery. Overall, 3,891 of the women had a vaginal delivery.

The researchers found that the primary outcome of postpartum hemorrhage of at least 500 ml occurred in 8.1 and 9.8 percent of women in the tranexamic acid and placebo groups, respectively (relative risk, 0.83; 95 percent confidence interval, 0.68 to 1.01; P = 0.07). Compared with those in the placebo group, women in the tranexamic acid group had a lower rate of provider-assessed clinically significant postpartum hemorrhage (7.8 versus 10.4 percent; relative risk, 0.74; 95 percent confidence interval, 0.61 to 0.91; P = 0.004) and received additional uterotonic agents less often (7.2 versus 9.7 percent; relative risk, 0.75; 95 percent confidence interval, 0.61 to 0.92; P = 0.006).

"Among with who received prophylactic oxytocin, the use of did not result in a rate of of at least 500 ml that was significantly lower than the rate with placebo," the authors write.

Explore further: Low cost, easy to administer drug may be the key to preventing maternal deaths

More information: Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

Low cost, easy to administer drug may be the key to preventing maternal deaths

January 29, 2018
Postpartum hemorrhage (major blood loss after labor and birth) is the leading cause of maternal mortality worldwide, accounting for approximately one-quarter of all maternal deaths. In a study to be presented at the Society ...

For postpartum hemorrhage, carbetocin similar to oxytocin

July 5, 2018
(HealthDay)—For women after vaginal birth, heat-stable carbetocin is non-inferior to oxytocin for prevention of blood loss of at least 500 ml or use of additional uterotonic agents, according to a study published online ...

Misoprostol doesn't cut risk of postpartum hemorrhage

September 20, 2016
(HealthDay)—For women in the third stage of labor, misoprostol administered with routine oxytocin does not reduce the rate of postpartum hemorrhage, according to a study published online Sept. 5 in Obstetrics & Gynecology.

ASA: tranexamic acid doesn't up death, thrombotic complications

October 26, 2016
(HealthDay)—Tranexamic acid is associated with a lower risk of bleeding than placebo for patients undergoing coronary artery surgery without increased risk of death or thrombotic complications, according to a study published ...

Labetalol use up for patients with preeclampsia and asthma

August 15, 2018
(HealthDay)—Higher rates of β-blocker use are seen among women with preeclampsia and asthma, according to a study published in the July issue of Obstetrics & Gynecology.

Definition of prolonged third-stage labor may be outdated

April 11, 2016
(HealthDay)—Postpartum hemorrhage risk is significantly elevated with a third-stage labor duration of 20 minutes or more, according to research published in the May issue of Obstetrics & Gynecology.

Recommended for you

Undiagnosed STIs can increase negative PMS symptoms

September 17, 2018
Women that have undiagnosed sexually transmitted infections may be at greater risk of experiencing negative premenstrual symptoms (PMS), according to new Oxford University research.

High dose folic acid does not prevent pre-eclampsia in high risk women

September 13, 2018
Taking high dose folic acid supplements in later pregnancy (beyond the first trimester) does not prevent pre-eclampsia in women at high risk for this condition, finds a randomised controlled trial published by The BMJ today.

Study finds air purifiers may benefit fetal growth

September 12, 2018
A new study led by SFU health sciences researchers Prabjit Barn and Ryan Allen reveals fetal growth may improve if pregnant women use portable air purifiers inside their homes.

Delayed childbearing is a growing source of multiple births, study shows

September 12, 2018
Starting in the 1980s, the number of multiple births—twins, triplets, quadruplets and quintuplets—steadily increased from about 20 sets per 1,000 live births to almost 35 sets per 1,000 live births in the 2010s.

Transforming pregnancy research with a smartphone app

September 5, 2018
For years, pregnant women have been underrepresented in biomedical research. Current treatments, interventions and guidelines do a poor job of taking into consideration the diverse characteristics of all pregnant women.

For women undergoing IVF, is fresh or frozen embryo transfer best?

August 21, 2018
The world's first baby born via in-vitro fertilization turned 40 years old this summer. Still, after four decades, IVF is a relatively new field with ongoing debate on how to get the best results for families who have placed ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.